Terapio

About:

Terapio is a biopharmaceutical company developing therapeutics based on the RLIP76 protein.

Top Investors: Sante Ventures, Texas Wide Open for Business

Description:

Terapio is developing a pipeline of therapies based on the normally-occurring transport protein RLIP76 that moves free-radical toxins out of cells before significant damage can occur. Although naturally present in cells, increasing the amount of this protein available to normal cells affords them an even greater ability to deal with toxins from a variety of sources, including chemicals and radiation.

Total Funding Amount:

$7.48M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2005-01-01

Contact Email:

terapio.admin(AT)terapio.com

Founders:

Casey Cunningham

Number of Employees:

1-10

Last Funding Date:

2015-07-21

IPO Status:

Private

Industries: